Loading…

Are positive experiences of children in non-therapeutic research justifiable research benefits?

BackgroundConducting non-therapeutic research is ethically challenging because participation conveys risks and burden and no health benefit. In this paper, we report the positive experiences of a diverse group of healthy and ill children (6–18 years) who participated in non-therapeutic research stud...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical ethics 2017-08, Vol.43 (8), p.530-534
Main Authors: Staphorst, Mira S, Hunfeld, Joke A M, van de Vathorst, Suzanne
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundConducting non-therapeutic research is ethically challenging because participation conveys risks and burden and no health benefit. In this paper, we report the positive experiences of a diverse group of healthy and ill children (6–18 years) who participated in non-therapeutic research studies and discuss whether these positive experiences can justifiably be viewed as benefits.MethodsWe used semistructured interviews from an earlier study about children's experiences in clinical research and did a secondary analysis on the positive experiences of the children in the non-therapeutic studies (N=30). Interviews were analysed using ‘thematic’ analysis.ResultsThe interviewed children most frequently mentioned as positive experiences of non-therapeutic research participation helping others and the gratification that comes with it, possible health benefits in the future, having fun and new/increased knowledge about the human body, hospitals and doing research. Less frequently mentioned were getting a present, not having to go to school and getting extra attention from healthcare staff.ConclusionsOur study shows that children participating in non-therapeutic research have various positive experiences while taking part. We argue that some of these justifiably could be taken into the risk–benefit analysis in certain situations or maybe even as a standard part of this analysis. This may help to increase the number of (crucial) non-therapeutic studies with children.
ISSN:0306-6800
1473-4257
DOI:10.1136/medethics-2016-103404